来自 Porphyra haitanensis 的糖蛋白的结构和抗糖尿病活性
Yujia Ou1,2, Lijingting Xu1, Mingrong Chen1
1College of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Journal of agricultural and food chemistry
|October 25, 2023
概括
来自Porphyra haitanensis的一种新型糖蛋白通过抑制参与碳水化合物消化中的关键酶,显示出显著的抗糖尿病潜力. 这种纯化的葡萄糖蛋白对开发糖尿病新疗法充满希望.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 海洋生物技术 海洋生物技术
背景情况:
- 2型糖尿病 (T2DM) 是一种全球性健康问题,其特点是高血糖.
- 抑制像α-氨酶和α-葡萄糖酶这样的碳水化合物解酶是管理T2DM的关键策略.
- 海洋生物,如藻类,是生物活性化合物的丰富来源,具有潜在的治疗应用.
研究的目的:
- 从Porphyra haitanensis中分离和净化一种新型的葡萄糖蛋白 (PG).
- 描述纯化PG的结构性质.
- 调查PG对α-氨酶和α-葡萄糖酶活性的抑制作用,并阐明其潜在机制.
主要方法:
- 使用标准生化技术将糖蛋白分离和净化.
- 结构特征包括分子量测定,亚单元分析,氨基酸和碳水化合物组成分析.
- 酶抑制试验对α-氨酶和α-葡萄糖酶进行检测.
- 分子对接模拟用于预测结合相互作用.
主要成果:
- 分离了一种新型的葡萄糖蛋白 (PG),其纯度为95.29%,分子量为163.024kDa.
- PG具有四聚体结构,含有阿尔法和β子单元,富含疏水性氨基酸和银河糖,通过O-糖化键连接在一起.
- 该PG表现出非竞争性抑制α-氨酶和α-葡萄糖酶,分子对接显示出疏水性相互作用和键作为关键的抑制机制.
结论:
- 来自Porphyra haitanensis的纯化糖蛋白具有显著的抗糖尿病特性.
- 它的低血糖活性归因于通过结构变化抑制α-氨酶和α-葡萄糖酶.
- 这项研究强调了海洋衍生型葡萄糖蛋白作为治疗糖尿病管理的治疗剂的潜力.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
184
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
184
Glucagon-like Receptor Agonists
334
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
334
Oral Hypoglycemic Agents: Glinides
160
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
160
Dipeptidyl Peptidase 4 Inhibitors
192
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
192
Insulin: Biosynthesis, Chemistry, and Preparation
393
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
393
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K


